Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 3;11(1):63.
doi: 10.3390/diagnostics11010063.

Application of Salivary Biomarkers in the Diagnosis of Fibromyalgia

Rebeca Illescas-Montes  1   2 , Víctor J Costela-Ruiz  1   2 , Lucía Melguizo-Rodríguez  1   2 , Elvira De Luna-Bertos  1   2 , Concepción Ruiz  1   2   3 , Javier Ramos-Torrecillas  1   2
Affiliations
Review

Application of Salivary Biomarkers in the Diagnosis of Fibromyalgia

Rebeca Illescas-Montes et al. Diagnostics (Basel). .

Abstract

Fibromyalgia (FM) is a highly prevalent syndrome that impairs the quality of life of the patients; however, its diagnosis is complex and mainly centered on pain symptoms. The study of salivary biomarkers has proven highly useful for the diagnosis and prognosis of numerous diseases. The objective of this review was to gather published data on the utilization of salivary biomarkers to facilitate and complement the diagnosis of FM. Salivary biomarkers used in FM diagnosis include cortisol; calgranulin; and the enzymes α-amylase, transaldolase, and phosphoglycerate mutase. Increased serum levels of C-reactive protein, cytokines interleukin 1-β, interleukin 6, interleukin 8, interleukin 10, interleukin 17, tumor necrosis factor α, and various chemokines may serve as salivary biomarkers, given observations of their increased serum levels in patients with FM. Further research is warranted to study in depth the role and performance of biomarkers currently used in FM diagnosis/prognosis and to identify novel salivary biomarkers for this disease.

Keywords: biomarkers; diagnosis; fibromyalgia; saliva.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Smith S.B., Maixner D.W., Fillingim R.B., Slade G., Gracely R.H., Ambrose K., Zaykin D.V., Hyde C., John S., Tan K., et al. Large Candidate Gene Association Study Reveals Genetic Risk Factors and Therapeutic Targets for Fibromyalgia. Arthritis Rheum. 2012;64:584–593. doi: 10.1002/art.33338. - DOI - PMC - PubMed
    1. Borchers A.T., Gershwin M.E. Fibromyalgia: A Critical and Comprehensive Review. Clin. Rev. Allergy. Immunol. 2015;49:100–151. doi: 10.1007/s12016-015-8509-4. - DOI - PubMed
    1. McLean S.A., Williams D.A., Harris R.E., Kop W.J., Groner K.H., Ambrose K., Lyden A.K., Gracely R.H., Crofford L.J., Geisser M.E., et al. Momentary Relationship between Cortisol Secretion and Symptoms in Patients with Fibromyalgia. Arthritis Rheum. 2005;52:3660–3669. doi: 10.1002/art.21372. - DOI - PubMed
    1. Ruggiero V., Era B., Cacace E., Molin L., Corda M., Fais A., Utzeri S. A Preliminary Study on Serum Proteomics in Fibromyalgia Syndrome. Clin. Chem. Lab. Med. (CCLM) 2014;52:e207–e210. doi: 10.1515/cclm-2014-0086. - DOI - PubMed
    1. Mendieta D., De la Cruz-Aguilera D.L., Barrera-Villalpando M.I., Becerril-Villanueva E., Arreola R., Hernández-Ferreira E., Pérez-Tapia S.M., Pérez-Sánchez G., Garcés-Alvarez M.E., Aguirre-Cruz L., et al. IL-8 and IL-6 Primarily Mediate the Inflammatory Response in Fibromyalgia Patients. J. Neuroimmunol. 2016;290:22–25. doi: 10.1016/j.jneuroim.2015.11.011. - DOI - PubMed